The National Cancer Data Base report on cancer of the head and neck

Archives of Otolaryngology - Head and Neck Surgery

Volumn 124, Issue 9, 1998, Pages 951-962

  Hoffman, Henry T ^a   Karnell, Lucy Hynds ^a   Funk, Gerry F ^a   Robinson, Robert A ^a   Menck, Herman R ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b National Cancer Data Base   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; DATA BASE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; UNITED STATES;

EID: 0031692489     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.124.9.951     Document Type: Article

References (53)

1. Mork J, Thoresen S, Hilde F-L, Langmark F, Glattre E. Head and neck cancer in Norway: a study of the quality of the cancer registry of Norway's data on head and neck cancer for the period 1953-1991. APMIS. 1995;103:375-382.
2. Bang G, Donath K, Thoresen S, Clausen OPF. DNA flow cytometry of reclassified subtypes of malignant salivary gland tumors. J Oral Pathol Med. 1994;23:291-297.
3. Fraumeni JF, Devesa SS, Hoover RN, Kinlen LJ. Epidemiology of cancer. In: DeVita VT. Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. 4th ed. Philadelphia, Pa: JB Lippincott Co; 1993:150-181.
4. van der Sanden GAC, Coebergh JWW, Schouten LJ, Visser O, van Leeuwen FE. Cancer incidence in the Netherlands in 1989 and 1990: first results of the Nationwide Netherlands Cancer Registry, Eur J Cancer. 1995;31A:1822-1829.
5. Hjalgrim J, Frisch M, Begtrup K, Melbye M. Recent increase in the incidence of non-Hodgkin's lymphoma among young men and women in Denmark. Br J Cancer. 1996;73:951-954.
6. Mattson B, Wallgren A. Completeness of the Swedish cancer register. Acts Radiol Oncol. 1984:23:305-313.
7. Jessup JM, Menck HR, Winchester DP, Hundahl SA, Murphy GP. The National Cancer Data Base report on patterns of hospital reporting. Cancer. 1996;78: 1829-1837.
8. Steele GD, Jessup JM, Winchester DP, Menck HR, Murphy GP. eds. National Cancer Data Base Annual Review of Patient Care, 1995. Atlanta. Ga: American Cancer Society: 1995.
9. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1992: Tables and Graphs. Bethesda, Md: National Cancer Institute; 1995. NIH publication 96-2789.
10. Reynolds T, National Statistics Source reaches 20th anniversary. J Natl Cancer Inst. 1993;85:1897-1899.
11. Mettlin CJ, Menck HR, Winchester DP, Murphy GP. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology. and End Results Program. Cancer. 1997: 79:2052-2061.
12. Hoffman HT, Karnell LH, Laryngeal cancer. In: Steele GD, Jessup JM, Winchester DP, Menck HR, Murphy GP, eds. National Cancer Data Base Annual Review of Patient Care 1995. Atlanta, Ga: American Cancer Society; 1995:84-99.
13. Hundahl SA, Fleming ID, Shah JP, Thyroid cancer. In: Steele GD, Jessup JM, Winchester DP, Menck HR, Murphy GP, eds. National Cancer Data Base Annual Review of Patient Care 1995. Atlanta, Ga: American Cancer Society; 1995: 100-112.
14. Commission on Cancer. Data Acquisition Manual. Chicago, III: Commission on Cancer, American College of Surgeons; 1990.
15. Commission on Cancer. Data Acquisition Manual. Revised Edition. Chicago, III: Data Standards Program of the Commission on Cancer, American College of Surgeons; 1994.
16. American Joint Committee on Cancer. Manual for Staging of Cancer. Philadelphia, Pa: JB Lippincott: 1978.
17. American Joint Committee on Cancer. Manual for Staging of Cancer. 2nd ed. Philadelphia, Pa: JB Lippincott; 1983.
18. Beahrs O, Henson DE, Hutter RVP, Kennedy BJ, eds. American Joint Committee on Cancer: Manual for Staging of Cancer. 3rd ed. Philadelphia, Pa: JB Lippincott; 1988.
19. Beahrs O, Henson DE, Butter RVP, Kennedy BJ, eds. American Joint Committee on Cancer: Manual for Staging of Cancer. 4th ed. Philadelphia, Pa: JB Lippincott; 1992.
20. Percy C, van Holten V, Muir C, eds. International Classification of Diseases for Oncology, Second Edition. Geneva, Switzerland: World Health Organization: 1990.
21. CACI Marketing Systems. 1990 Sourcebook of ZIP Code Demographics. Tape and File Documentation. Arlington, Va: CACI Inc; 1992.
22. Carriaga MT, Henson DE, The histologic grading of cancer. Cancer, 1995;75: 406-421.
23. SPSS Inc. SPSS Users' Guide: Release 7.5. Chicago. III: SPSS Inc: 1997.
24. Boring CC, Squires TS, Tong T, Montgomery S, Cancer statistics. CA Cancer J Clin. 1994;44:7-26.
25. Miller BA, Kolonel LN, Bernstein L, et al. eds. Racial/Ethnic Patterns of Cancer in the United States, 1988-1992. Bethesda. Md: National Cancer Institute; 1996. NIH publication 96-4104.
26. Levi F, La Vecchia C, Lucchini F, Negri E. Worldwide trends in cancer mortality in the elderly, 1955-1992. Eur J Cancer. 1996;32A:652-672.
27. Jessup JM, Steele GD, Winchester DP. Introduction. In: Steele GD, Jessup JM, Winchester DP, Menck HR, Murphy GP, eds. National Cancer Data Base Annual Review of Patient Care 1995. Atlanta, Ga: American Cancer Society; 1995:1-11.
28. Lee K, Strauss M, Head and neck cancer in blacks. J Natl Med Assoc. 1994;86: 530-534.
29. Spitz M, Epidemiology and risk factors for head and neck cancer. Semin Oncol. 1994;21:281-288.
30. Walker B, Figgs LW, Zahm SH. Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect. 1995; 103(suppl 8):275-281.
31. Zheng T, Holford TR, Chen Y, et al. Time trend and age-period cohort effect on incidence of thyroid cancer in Connecticut: 1935-1992. Int J Cancer. 1996;67: 504-509.
32. Ron E, Saftlas AF, Head and neck radiation carcinogenesis: epidemiologic evidence. Otolaryngol Head Neck Surg. 1996;115:403-408.
33. Deandrea M, Gallone G, Veglio M, et al. Thyroid cancer histotype changes as observed in a major general hospital in a 21-year period. J Endocrinol Invest. 1997; 20:52-58.
34. Tobias JS. Cancer of the head and neck. BMJ. 1994;308:961-966.
35. Carrie S, Start RD, Goepel JR. The changing incidence of head and neck extranodal non-Hodgkin's lymptoma: 25 years experience [abstract]. J Pathol. 1996; 178:39.
36. Fleming ID, Phillips JL, Menck HR. The National Cancer Data Base report on completeness of American Joint Committee on Cancer Staging in the United States cancer facilities. Cancer. 1996;78:1498-1504.
37. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW. Fuks ZY. Malignant tumors of major salivary gland origin. Arch Otolaryngol Head Neck Surg. 1990; 116:290-293.
38. Gaughan RK, Olsen KD, Lewis JE. Primary squamous cell carcinoma of the parotid gland. Arch Otolaryngol Head Neck Surg. 1992;118:798-801.
39. Ellis GL, Auclair PL, Malignant epithelial tumors. In: Rosai J, Sobin LH. eds. Tumors of the Salivary Glands, Third Series Fascicle 17 of Atlas of Tumor Pathology. Bethesda, Md: Armed Forces Institute of Pathology; 1996:251.
40. Freeman H. Cancer in the economically disadvantaged. Cancer. 1989:64(suppl): 324-333.
41. Lefebvre JL, Chevalier D, Luboinski B, KirkpatrickA, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst. 1996;88:890-899.
42. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685-1690.
43. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med. 1993;328:184-194.
44. Robbins KT, Storniolo AM, Hryniuk WM, et al. "Decadose" effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. Laryngoscope. 1996; 106:37-42.
45. Harari PM, Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? J Clin Oncol. 1997: 15:2050-2055.
46. Tomio L, Zorat PL, Paccagnella A, et al. A pilot study of concomitant radiation and chemotherapy in patients with locally advanced head and neck cancer. Am J Clin Oncol. 1993;16:264-267.
47. Giri PG, LeBlanc M, Al Sarraf M, et al. Improved survival with chemotherapy and radiation therapy versus radiation therapy alone in advanced nasopharyngeal cancer: preliminary results of an intergroup randomized trial (Int 0099, SWOG 8892, RTOG 8817, ECOG 2388) [abstract]. Int J Radiat Oncol Biol Phys. 1996:36(suppl):251.
48. Boysen M, Natvig K, Winterh O, Tausjo J, Value of routine follow-up in patients treated for squamous cell carcinoma of the head and neck. J Otolaryngol. 1985; 14:211-214.
49. Snow G. Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long. Eur J Cancer. 1992;28:315-316.
50. Hoffman HT, Funk G, Endres D. Evaluation and surgical treatment of tumors of the salivary glands. In: Thawley S, Panje W, eds. Comprehensive Management of Head and Neck Tumors. 2nd ed. Philadelphia, Pa: WB Saunders Co. In press.
51. Hoffman HT, Karnell LH, Shah JP, et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope. 1997;107:1005-1017.
52. Jesse R, Sugarbaker E. Squamous cell carcinoma of the oropharynx: why we fail. Otolaryngol Head Neck Surg. 1976;132:435-438.
53. Hoffman HT, Krause CJ, Eschwege F. Combined surgery and radiotherapy. In: Snow GB, Clark JR, eds. Multimodality Therapy for Head and Neck Cancer. New York, NY: Thieme Medical Publishers Inc; 1992:76-94.